A citation-based method for searching scientific literature

K Damm, U Hemmann, P Garin-Chesa, N Hauel, I Kauffmann, H Priepke, C Niestroj, C Daiber, B Enenkel, B Guilliard, I Lauritsch, E Müller, E Pascolo, G Sauter, M Pantic, U M Martens, C Wenz, J Lingner, N Kraut, W J Rettig, A Schnapp. EMBO J 2001
Times Cited: 308







List of co-cited articles
1474 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Mechanism of human telomerase inhibition by BIBR1532, a synthetic, non-nucleosidic drug candidate.
Emanuelle Pascolo, Christian Wenz, Joachim Lingner, Norbert Hauel, Henning Priepke, Iris Kauffmann, Pilar Garin-Chesa, Wolfgang J Rettig, Klaus Damm, Andreas Schnapp. J Biol Chem 2002
188
45

Specific association of human telomerase activity with immortal cells and cancer.
N W Kim, M A Piatyszek, K R Prowse, C B Harley, M D West, P L Ho, G M Coviello, W E Wright, S L Weinrich, J W Shay. Science 1994
38

Selective cytotoxicity and telomere damage in leukemia cells using the telomerase inhibitor BIBR1532.
Hesham El-Daly, Miriam Kull, Stefan Zimmermann, Milena Pantic, Cornelius F Waller, Uwe M Martens. Blood 2005
103
29


Telomerase and cancer therapeutics.
Calvin B Harley. Nat Rev Cancer 2008
472
23


Telomeres shorten during ageing of human fibroblasts.
C B Harley, A B Futcher, C W Greider. Nature 1990
19

TERT promoter mutations in familial and sporadic melanoma.
Susanne Horn, Adina Figl, P Sivaramakrishna Rachakonda, Christine Fischer, Antje Sucker, Andreas Gast, Stephanie Kadel, Iris Moll, Eduardo Nagore, Kari Hemminki,[...]. Science 2013
19

In vivo inhibition of lung cancer by GRN163L: a novel human telomerase inhibitor.
Z Gunnur Dikmen, Ginelle C Gellert, Shalmica Jackson, Sergei Gryaznov, Robert Tressler, Pakize Dogan, Woodring E Wright, Jerry W Shay. Cancer Res 2005
175
18

Telomere shortening and growth inhibition of human cancer cells by novel synthetic telomerase inhibitors MST-312, MST-295, and MST-1991.
Hiroyuki Seimiya, Tomoko Oh-hara, Tsuneji Suzuki, Imad Naasani, Toshiyuki Shimazaki, Katsutoshi Tsuchiya, Takashi Tsuruo. Mol Cancer Ther 2002
95
18

Highly recurrent TERT promoter mutations in human melanoma.
Franklin W Huang, Eran Hodis, Mary Jue Xu, Gregory V Kryukov, Lynda Chin, Levi A Garraway. Science 2013
18

Inhibition of telomerase limits the growth of human cancer cells.
W C Hahn, S A Stewart, M W Brooks, S G York, E Eaton, A Kurachi, R L Beijersbergen, J H Knoll, M Meyerson, R A Weinberg. Nat Med 1999
848
17

A survey of telomerase activity in human cancer.
J W Shay, S Bacchetti. Eur J Cancer 1997
17

Hallmarks of cancer: the next generation.
Douglas Hanahan, Robert A Weinberg. Cell 2011
16

Antitelomerase therapy provokes ALT and mitochondrial adaptive mechanisms in cancer.
Jian Hu, Soyoon Sarah Hwang, Marc Liesa, Boyi Gan, Ergun Sahin, Mariela Jaskelioff, Zhihu Ding, Haoqiang Ying, Adam T Boutin, Hailei Zhang,[...]. Cell 2012
183
16

TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal.
Patrick J Killela, Zachary J Reitman, Yuchen Jiao, Chetan Bettegowda, Nishant Agrawal, Luis A Diaz, Allan H Friedman, Henry Friedman, Gary L Gallia, Beppino C Giovanella,[...]. Proc Natl Acad Sci U S A 2013
860
16

Structure of the Tribolium castaneum telomerase catalytic subunit TERT.
Andrew J Gillis, Anthony P Schuller, Emmanuel Skordalakes. Nature 2008
189
15

Mammalian telomeres end in a large duplex loop.
J D Griffith, L Comeau, S Rosenfield, R M Stansel, A Bianchi, H Moss, T de Lange. Cell 1999
15

Telomerase catalytic subunit homologs from fission yeast and human.
T M Nakamura, G B Morin, K B Chapman, S L Weinrich, W H Andrews, J Lingner, C B Harley, T R Cech. Science 1997
15

A novel telomerase template antagonist (GRN163) as a potential anticancer agent.
Akira Asai, Yuko Oshima, Yoshihiro Yamamoto, Taka-aki Uochi, Hideaki Kusaka, Shiro Akinaga, Yoshinori Yamashita, Krisztina Pongracz, Ronald Pruzan, Ellen Wunder,[...]. Cancer Res 2003
152
15

Telomerase template antagonist GRN163L disrupts telomere maintenance, tumor growth, and metastasis of breast cancer.
Amelia E Hochreiter, Hongling Xiao, Erin M Goldblatt, Sergei M Gryaznov, Kathy D Miller, Sunil Badve, George W Sledge, Brittney-Shea Herbert. Clin Cancer Res 2006
98
14

A DNA damage checkpoint response in telomere-initiated senescence.
Fabrizio d'Adda di Fagagna, Philip M Reaper, Lorena Clay-Farrace, Heike Fiegler, Philippa Carr, Thomas Von Zglinicki, Gabriele Saretzki, Nigel P Carter, Stephen P Jackson. Nature 2003
14


Telomerase modulates Wnt signalling by association with target gene chromatin.
Jae-Il Park, Andrew S Venteicher, Ji Yeon Hong, Jinkuk Choi, Sohee Jun, Marina Shkreli, Woody Chang, Zhaojing Meng, Peggie Cheung, Hong Ji,[...]. Nature 2009
437
14

Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity.
C M Counter, A A Avilion, C E LeFeuvre, N G Stewart, C W Greider, C B Harley, S Bacchetti. EMBO J 1992
13


Structural Basis of Telomerase Inhibition by the Highly Specific BIBR1532.
Christopher Bryan, Cory Rice, Hunter Hoffman, Michael Harkisheimer, Melanie Sweeney, Emmanuel Skordalakes. Structure 2015
40
32

The serial cultivation of human diploid cell strains.
L HAYFLICK, P S MOORHEAD. Exp Cell Res 1961
12

Mammalian telomeres resemble fragile sites and require TRF1 for efficient replication.
Agnel Sfeir, Settapong T Kosiyatrakul, Dirk Hockemeyer, Sheila L MacRae, Jan Karlseder, Carl L Schildkraut, Titia de Lange. Cell 2009
642
12


Extension of life-span by introduction of telomerase into normal human cells.
A G Bodnar, M Ouellette, M Frolkis, S E Holt, C P Chiu, G B Morin, C B Harley, J W Shay, S Lichtsteiner, W E Wright. Science 1998
12

Telomerase activity in human germline and embryonic tissues and cells.
W E Wright, M A Piatyszek, W E Rainey, W Byrd, J W Shay. Dev Genet 1996
954
12

The RNA component of human telomerase.
J Feng, W D Funk, S S Wang, S L Weinrich, A A Avilion, C P Chiu, R R Adams, E Chang, R C Allsopp, J Yu. Science 1995
12

DNA damage foci at dysfunctional telomeres.
Hiroyuki Takai, Agata Smogorzewska, Titia de Lange. Curr Biol 2003
973
12

Activity of a novel G-quadruplex-interactive telomerase inhibitor, telomestatin (SOT-095), against human leukemia cells: involvement of ATM-dependent DNA damage response pathways.
Tetsuzo Tauchi, Kazuo Shin-Ya, Goro Sashida, Masahiko Sumi, Akihiro Nakajima, Takashi Shimamoto, Junko H Ohyashiki, Kazuma Ohyashiki. Oncogene 2003
152
11

How shelterin protects mammalian telomeres.
Wilhelm Palm, Titia de Lange. Annu Rev Genet 2008
11

Telomerase inhibition, telomere shortening, and senescence of cancer cells by tea catechins.
I Naasani, H Seimiya, T Tsuruo. Biochem Biophys Res Commun 1998
186
11

hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization.
M Meyerson, C M Counter, E N Eaton, L W Ellisen, P Steiner, S D Caddle, L Ziaugra, R L Beijersbergen, M J Davidoff, Q Liu,[...]. Cell 1997
11

Telomerase inhibition by non-nucleosidic compound BIBR1532 causes rapid cell death in pre-B acute lymphoblastic leukemia cells.
Davood Bashash, Seyed H Ghaffari, Rooholah Mirzaee, Kamran Alimoghaddam, Ardeshir Ghavamzadeh. Leuk Lymphoma 2013
21
52

Alternative lengthening of telomeres: models, mechanisms and implications.
Anthony J Cesare, Roger R Reddel. Nat Rev Genet 2010
572
11

Novel anticancer therapeutics targeting telomerase.
Maria Ruden, Neelu Puri. Cancer Treat Rev 2013
191
11

The telomerase reverse transcriptase regulates chromatin state and DNA damage responses.
Kenkichi Masutomi, Richard Possemato, Judy M Y Wong, Jennifer L Currier, Zuzana Tothova, Judith B Manola, Shridar Ganesan, Peter M Lansdorp, Kathleen Collins, William C Hahn. Proc Natl Acad Sci U S A 2005
258
11

A randomized phase II study of the telomerase inhibitor imetelstat as maintenance therapy for advanced non-small-cell lung cancer.
A A Chiappori, T Kolevska, D R Spigel, S Hager, M Rarick, S Gadgeel, N Blais, J Von Pawel, L Hart, M Reck,[...]. Ann Oncol 2015
87
12

Systematic analysis of telomere length and somatic alterations in 31 cancer types.
Floris P Barthel, Wei Wei, Ming Tang, Emmanuel Martinez-Ledesma, Xin Hu, Samirkumar B Amin, Kadir C Akdemir, Sahil Seth, Xingzhi Song, Qianghu Wang,[...]. Nat Genet 2017
222
11

Telomestatin, a potent telomerase inhibitor that interacts quite specifically with the human telomeric intramolecular g-quadruplex.
Mu-Yong Kim, Hariprasad Vankayalapati, Kazuo Shin-Ya, Konstanty Wierzba, Laurence H Hurley. J Am Chem Soc 2002
371
10

Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging.
Elizabeth H Blackburn, Carol W Greider, Jack W Szostak. Nat Med 2006
565
10

Telomerase antagonists GRN163 and GRN163L inhibit tumor growth and increase chemosensitivity of human hepatoma.
Meta W Djojosubroto, Allison C Chin, Ning Go, Sonja Schaetzlein, Michael P Manns, Sergei Gryaznov, Calvin B Harley, K Lenhard Rudolph. Hepatology 2005
97
10

Imetelstat (GRN163L)--telomerase-based cancer therapy.
Alexander Röth, Calvin B Harley, Gabriela M Baerlocher. Recent Results Cancer Res 2010
70
14

A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes.
R K Moyzis, J M Buckingham, L S Cram, M Dani, L L Deaven, M D Jones, J Meyne, R L Ratliff, J R Wu. Proc Natl Acad Sci U S A 1988
10



Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.